AntibioTx signs 150 M DKK financing agreement with The European Investment Bank

October 26, 2017
AntibioTx A/S

AntibioTx A/S has signed a 150 M DKK (20 M EUR) financing agreement with the European Investment Bank to support late-stage clinical trials for the lead candidate ATx201. ATx201 represents a new class of antibiotics with a novel mode of action and is being developed as an innovative treatment for bacterial skin infections.

Read more here